Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class

Bibliographic Details
Main Authors:	Ahmed Bagit, BSc, Khalad Maliyar, MD, Jorge R. Georgakopoulos, MD, Brian Rankin, BSc, Alexander Rimke, MSc, Asfandyar Mufti, MD, Heather Le, CRC, Ronald Vender, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	JAAD International
Subjects:	biologic efficacy guselkumab IL-23 inhibitor psoriasis risankizumab
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328723000780

Internet